{
    "clinical_study": {
        "@rank": "104415", 
        "brief_summary": {
            "textblock": "This study will look at whether emtricitabine is as safe and effective as abacavir (ABC)\n      when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken\n      anti-HIV drugs."
        }, 
        "brief_title": "A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients are randomized to receive open-label emtricitabine or ABC in combination with\n      stavudine and efavirenz. Viral load and CD4+ cell counts are compared at Weeks 24 and 48.\n      Patients are followed for 48 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        You may be eligible if you:\n\n          -  Are HIV-positive and generally healthy.\n\n          -  Have a viral load of 5,000 copies/ml or more.\n\n          -  Have CD4 cell counts of 200 cells/mm3 or more.\n\n          -  Are age 18 or older.\n\n          -  Agree to practice sexual abstinence or use effective barrier methods of birth control\n             (such as condoms).\n\n        Exclusion Criteria\n\n        You will not be eligible if you:\n\n          -  Have ever taken anti-HIV drugs for 3 days or more.\n\n          -  Have had certain AIDS-related infections.\n\n          -  Have had severe diarrhea within the past 30 days.\n\n          -  Are unable to eat at least 1 meal a day due to nausea, vomiting, or stomach pain.\n\n          -  Are being treated for active tuberculosis (TB).\n\n          -  Are pregnant or breast-feeding.\n\n          -  Use illegal drugs or alcohol that make it difficult for you to take study drugs or\n             keep clinic appointments.\n\n          -  Are taking certain medications, or have certain other conditions or diseases (see the\n             technical summary for more detail)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002362", 
            "org_study_id": "298B", 
            "secondary_id": "FTC-301"
        }, 
        "intervention": [
            {
                "intervention_name": "Abacavir sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Efavirenz", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Emtricitabine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Stavudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Stavudine", 
                "Reverse Transcriptase Inhibitors", 
                "Efavirenz", 
                "Abacavir", 
                "Anti-HIV Agents", 
                "Emtricitabine"
            ]
        }, 
        "keyword": [
            "Dideoxynucleosides", 
            "Drug Therapy, Combination", 
            "Stavudine", 
            "Reverse Transcriptase Inhibitors", 
            "abacavir", 
            "efavirenz"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95814"
                    }, 
                    "name": "Ctr for AIDS Research / Education and Service (CARES)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94121"
                    }, 
                    "name": "San Francisco Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "Gary Richmond MD"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60657"
                    }, 
                    "name": "Northstar Med Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Somers Point", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08244"
                    }, 
                    "name": "South Jersey Infectious Diseases Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manhasset", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11030"
                    }, 
                    "name": "North Shore Univ Hosp / Div of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr of Dallas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77006"
                    }, 
                    "name": "Houston Clinical Research Network"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Univ of Texas / Med School at Houston"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284"
                    }, 
                    "name": "Univ of Texas Health Sciences Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized, Open-Label Superiority Trial Comparing Emtricitabine to Abacavir Within a Triple Drug Combination in Antiretroviral-Drug Naive HIV-1 Infected Patients", 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002362"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Triangle Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 1999", 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2000"
    }, 
    "geocoordinates": {
        "Ctr for AIDS Research / Education and Service (CARES)": "38.582 -121.494", 
        "Gary Richmond MD": "26.122 -80.143", 
        "Houston Clinical Research Network": "29.76 -95.369", 
        "North Shore Univ Hosp / Div of Infectious Diseases": "40.798 -73.7", 
        "Northstar Med Clinic": "41.878 -87.63", 
        "San Francisco Veterans Administration Med Ctr": "37.775 -122.419", 
        "South Jersey Infectious Diseases Inc": "39.318 -74.595", 
        "Univ of Texas / Med School at Houston": "29.76 -95.369", 
        "Univ of Texas Health Sciences Ctr": "29.424 -98.494", 
        "Univ of Texas Southwestern Med Ctr of Dallas": "32.803 -96.77"
    }
}